Significance of an estradiol plateau or drop following the GnRH antagonist Antagon™ administration in patients stimulated with recombinant FSH
W.D. Hazlett, V.C. Karande, P.A. Mangan, L.R. Meyer, T.E. NastaVolume:
82
Year:
2004
Language:
english
DOI:
10.1016/j.fertnstert.2004.07.602
File:
PDF, 54 KB
english, 2004